Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPD-17010521Phase 4Recruiting
Phase 4, randomised trial of ropivacaine, sufentanil and hydromorphone in labor pain (3 arms), sponsored by Department of Anesthesiology, Pain Medicine & Critical Care Medicine, Aviation General Hospital of China Medical University & Beijing Institute of Translational Medicine, Chinese Academy of Sciences. Primary endpoints: Pain intensity (visual analogue scale) and Maternal complications. Started Mar 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPD-17010521.